137 related articles for article (PubMed ID: 38197598)
1. Role of the CCL20/CCR6 axis in tubular epithelial cell injury: Kidney-specific translational insights from acute kidney injury to chronic kidney disease.
Yoo KD; Yu MY; Kim KH; Lee S; Park E; Kang S; Lim DH; Lee Y; Song J; Kown S; Kim YC; Kim DK; Lee JS; Kim YS; Yang SH
FASEB J; 2024 Jan; 38(2):e23407. PubMed ID: 38197598
[TBL] [Abstract][Full Text] [Related]
2. CCL20 blockade increases the severity of nephrotoxic folic acid-induced acute kidney injury.
González-Guerrero C; Morgado-Pascual JL; Cannata-Ortiz P; Ramos-Barron MA; Gómez-Alamillo C; Arias M; Mezzano S; Egido J; Ruiz-Ortega M; Ortiz A; Ramos AM
J Pathol; 2018 Oct; 246(2):191-204. PubMed ID: 29984403
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.
Hammerich L; Bangen JM; Govaere O; Zimmermann HW; Gassler N; Huss S; Liedtke C; Prinz I; Lira SA; Luedde T; Roskams T; Trautwein C; Heymann F; Tacke F
Hepatology; 2014 Feb; 59(2):630-42. PubMed ID: 23959575
[TBL] [Abstract][Full Text] [Related]
4. Chemokine CCL20 promotes the paclitaxel resistance of CD44
Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
[TBL] [Abstract][Full Text] [Related]
5. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
[TBL] [Abstract][Full Text] [Related]
6. SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation.
Hanna DN; Smith PM; Novitskiy SV; Washington MK; Zi J; Weaver CJ; Hamaamen JA; Lewis KB; Zhu J; Yang J; Liu Q; Beauchamp RD; Means AL
Gastroenterology; 2022 Nov; 163(5):1334-1350.e14. PubMed ID: 35863523
[TBL] [Abstract][Full Text] [Related]
7. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
[TBL] [Abstract][Full Text] [Related]
8. Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis.
Park JY; Yoo KD; Bae E; Kim KH; Lee JW; Shin SJ; Lee JS; Kim YS; Yang SH
Am J Physiol Renal Physiol; 2022 May; 322(5):F553-F572. PubMed ID: 35311382
[TBL] [Abstract][Full Text] [Related]
9. CCR6-CCL20 axis as a therapeutic target for autoimmune diseases.
Meitei HT; Jadhav N; Lal G
Autoimmun Rev; 2021 Jul; 20(7):102846. PubMed ID: 33971346
[TBL] [Abstract][Full Text] [Related]
10. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.
Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.
Jin P; Shin SH; Chun YS; Shin HW; Shin YJ; Lee Y; Kim D; Nam DH; Park JW
Oncogene; 2018 Jun; 37(23):3070-3087. PubMed ID: 29535421
[TBL] [Abstract][Full Text] [Related]
12. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.
Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS
PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282
[TBL] [Abstract][Full Text] [Related]
13. The relationship between CCR6 and its binding partners: does the CCR6-CCL20 axis have to be extended?
Lee AY; Phan TK; Hulett MD; Körner H
Cytokine; 2015 Mar; 72(1):97-101. PubMed ID: 25585877
[TBL] [Abstract][Full Text] [Related]
14. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.
Hirota K; Yoshitomi H; Hashimoto M; Maeda S; Teradaira S; Sugimoto N; Yamaguchi T; Nomura T; Ito H; Nakamura T; Sakaguchi N; Sakaguchi S
J Exp Med; 2007 Nov; 204(12):2803-12. PubMed ID: 18025126
[TBL] [Abstract][Full Text] [Related]
15. CCL20-CCR6 axis modulated traumatic brain injury-induced visual pathologies.
Das M; Tang X; Han JY; Mayilsamy K; Foran E; Biswal MR; Tzekov R; Mohapatra SS; Mohapatra S
J Neuroinflammation; 2019 May; 16(1):115. PubMed ID: 31151410
[TBL] [Abstract][Full Text] [Related]
16. Panel of miR-150 and linc00673, regulators of CCR6/CCL20 may serve as non-invasive diagnostic marker of non-small cell lung cancer.
Baran K; Kordiak J; Jabłoński S; Brzeziańska-Lasota E
Sci Rep; 2023 Jun; 13(1):9642. PubMed ID: 37316552
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived CCL20 affects B16 melanoma growth in mice.
Martin-Garcia D; Silva-Vilches C; Will R; Enk AH; Lonsdorf AS
J Dermatol Sci; 2020 Jan; 97(1):57-65. PubMed ID: 31883833
[TBL] [Abstract][Full Text] [Related]
18. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells.
Skovdahl HK; Granlund Av; Østvik AE; Bruland T; Bakke I; Torp SH; Damås JK; Sandvik AK
PLoS One; 2015; 10(11):e0141710. PubMed ID: 26536229
[TBL] [Abstract][Full Text] [Related]
19. PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment.
Liu Y; Wei D; Deguchi Y; Xu W; Tian R; Liu F; Xu M; Mao F; Li D; Chen W; Valentin LA; Deguchi E; Yao JC; Shureiqi I; Zuo X
Gastric Cancer; 2023 Nov; 26(6):904-917. PubMed ID: 37572185
[TBL] [Abstract][Full Text] [Related]
20. In situ expression of the CCL20-CCR6 axis in lymphocyte-rich gastric cancer and its potential role in the formation of lymphoid stroma.
Ohtani H; Nakayama T; Yoshie O
Pathol Int; 2011 Nov; 61(11):645-51. PubMed ID: 22029675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
